159 related articles for article (PubMed ID: 2778240)
1. Major basic protein and eosinophil-derived neurotoxin concentrations in nasal-lavage fluid after antigen challenge: effect of systemic corticosteroids and relationship to eosinophil influx.
Bascom R; Pipkorn U; Proud D; Dunnette S; Gleich GJ; Lichtenstein LM; Naclerio RM
J Allergy Clin Immunol; 1989 Sep; 84(3):338-46. PubMed ID: 2778240
[TBL] [Abstract][Full Text] [Related]
2. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment.
Bascom R; Pipkorn U; Lichtenstein LM; Naclerio RM
Am Rev Respir Dis; 1988 Aug; 138(2):406-12. PubMed ID: 3195836
[TBL] [Abstract][Full Text] [Related]
3. [Cell activation markers in rhinitis and rhinosinusitis. 1: Eosinophilic cationic protein (ECP)].
Klimek L; Rasp G
Laryngorhinootologie; 1996 Nov; 75(11):665-70. PubMed ID: 9063834
[TBL] [Abstract][Full Text] [Related]
4. Eosinophil degranulation. An immunologic determinant in the pathogenesis of the Mazzotti reaction in human onchocerciasis.
Ackerman SJ; Kephart GM; Francis H; Awadzi K; Gleich GJ; Ottesen EA
J Immunol; 1990 May; 144(10):3961-9. PubMed ID: 2332637
[TBL] [Abstract][Full Text] [Related]
5. Extracellular deposition of eosinophil and neutrophil granule proteins in the IgE-mediated cutaneous late phase reaction.
Leiferman KM; Fujisawa T; Gray BH; Gleich GJ
Lab Invest; 1990 May; 62(5):579-89. PubMed ID: 2188046
[TBL] [Abstract][Full Text] [Related]
6. Blood eosinophils and eosinophil-derived proteins in allergic asthma.
Durham SR; Loegering DA; Dunnette S; Gleich GJ; Kay AB
J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):931-6. PubMed ID: 2480971
[TBL] [Abstract][Full Text] [Related]
7. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis.
Di Lorenzo G; Drago A; Esposito Pellitteri M; Candore G; Colombo A; Gervasi F; Pacor ML; Purello D'Ambrosio F; Caruso C
Int Arch Allergy Immunol; 2001 Jun; 125(2):164-75. PubMed ID: 11435734
[TBL] [Abstract][Full Text] [Related]
8. Hot, humid air increases cellular influx during the late-phase response to nasal challenge with antigen.
Assanasen P; Baroody FM; Naureckas E; Naclerio RM
Clin Exp Allergy; 2001 Dec; 31(12):1913-22. PubMed ID: 11737044
[TBL] [Abstract][Full Text] [Related]
9. Eosinophil inflammation of the nasal mucosa in allergic and non-allergic rhinitis measured by eosinophil cationic protein levels in native nasal fluid and serum.
Rasp G; Thomas PA; Bujía J
Clin Exp Allergy; 1994 Dec; 24(12):1151-6. PubMed ID: 7889429
[TBL] [Abstract][Full Text] [Related]
10. Assessment of eosinophil and neutrophil participation in atopic dermatitis: comparison with the IgE-mediated late-phase reaction.
Ott NL; Gleich GJ; Peterson EA; Fujisawa T; Sur S; Leiferman KM
J Allergy Clin Immunol; 1994 Jul; 94(1):120-8. PubMed ID: 8027490
[TBL] [Abstract][Full Text] [Related]
11. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators.
Sedgwick JB; Calhoun WJ; Gleich GJ; Kita H; Abrams JS; Schwartz LB; Volovitz B; Ben-Yaakov M; Busse WW
Am Rev Respir Dis; 1991 Dec; 144(6):1274-81. PubMed ID: 1741538
[TBL] [Abstract][Full Text] [Related]
12. Effect of slow-release theophylline on nasal antigen challenge in subjects with allergic rhinitis.
Aubier M; Neukirch C; Maachi M; Boucara D; Engelstätter R; Steinijans V; Samoyeau R; Dehoux M
Eur Respir J; 1998 May; 11(5):1105-10. PubMed ID: 9648963
[TBL] [Abstract][Full Text] [Related]
13. Eosinophils and eosinophil cationic protein in nasal lavages in allergen-induced hyperresponsiveness: effects of topical glucocorticosteroid treatment.
Andersson M; Andersson P; Venge P; Pipkorn U
Allergy; 1989 Jul; 44(5):342-8. PubMed ID: 2669553
[TBL] [Abstract][Full Text] [Related]
14. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils.
Kita H; Abu-Ghazaleh RI; Sur S; Gleich GJ
J Immunol; 1995 May; 154(9):4749-58. PubMed ID: 7722326
[TBL] [Abstract][Full Text] [Related]
15. [Study on eosinophil cationic protein (ECP) and arylsulfatase B in nasal secretions and sera from patients with nasal allergy].
Satoh K; Takagi I; Itoh H; Baba S
Nihon Jibiinkoka Gakkai Kaiho; 1991 Jun; 94(6):786-93. PubMed ID: 1886031
[TBL] [Abstract][Full Text] [Related]
16. Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo.
Cottin V; Deviller P; Tardy F; Cordier JF
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):116-23. PubMed ID: 9449510
[TBL] [Abstract][Full Text] [Related]
17. Eosinophil granule proteins in peripheral blood granulocytes.
Abu-Ghazaleh RI; Dunnette SL; Loegering DA; Checkel JL; Kita H; Thomas LL; Gleich GJ
J Leukoc Biol; 1992 Dec; 52(6):611-8. PubMed ID: 1464733
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil markers in seasonal allergic rhinitis. Intranasal fluticasone propionate inhibits local and systemic increases during the pollen season.
Nielsen LP; Bjerke T; Christensen MB; Skamling M; Peterson CG; Mygind N; Dahl R
Allergy; 1998 Aug; 53(8):778-85. PubMed ID: 9722227
[TBL] [Abstract][Full Text] [Related]
19. Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge.
Ciprandi G; Tosca MA; Passalacqua G; Canonica GW
Ann Allergy Asthma Immunol; 2001 Apr; 86(4):433-8. PubMed ID: 11345288
[TBL] [Abstract][Full Text] [Related]
20. [Topical eosinophil responses after allergen challenge in patients with nasal allergy].
Narita S; Saito H; Asakura K; Shirasaki H; Kataura A
Nihon Jibiinkoka Gakkai Kaiho; 1994 Jun; 97(6):1062-9. PubMed ID: 8051595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
